dr. brahmer on chemoimmunotherapy in patients with nsclc
Published 5 years ago • 75 plays • Length 1:25Download video MP4
Download video MP3
Similar videos
-
1:31
dr. brahmer on the role of immunotherapy in metastatic nsclc
-
1:14
dr. brahmer on immunotherapy in stage iv nsclc
-
2:19
dr brahmer on the investigation of flx475 in nsclc
-
0:31
copy of dr. brahmer on the role of immunotherapy in metastatic nsclc
-
1:15
dr. brahmer on immunotherapy beyond pd-1/l1 in nsclc
-
1:41
dr. brahmer discusses second-line pembrolizumab in nsclc
-
6:40
chemotherapy/immunotherapy combinations in lung cancer
-
1:18
dr. brahmer on 5-year follow-up data for nivolumab in nsclc
-
1:05
dr. brahmer on the impower150 trial in nsclc
-
1:48
dr. brahmer discusses frontline single-agent pembrolizumab in lung cancer
-
1:32
dr. brahmer on the benefit of immunotherapy in metastatic nsclc
-
1:29
dr. brahmer on managing immune-related aes in lung cancer
-
1:54
dr. brahmer on impact of checkmate-057 in nsclc
-
4:53
chemo-immunotherapy in nsclc: the keynote-189 trial
-
1:59
dr. brahmer on side effects of immunotherapy for lung cancer
-
1:13
dr. felip on immunotherapy alone or in combination in lung cancer
-
0:58
dr. julie r. brahmer on immunotherapy development in lung cancer
-
0:19
copy of dr. brahmer on immunotherapy in stage iv nsclc
-
0:57
dr. decker discusses aes associated with radiation in lung cancer